Versican V2 and the central inhibitory domain of Nogo-A inhibit neurite growth via p75NTR/NgR-independent pathways that converge at RhoA. (Q51822782)
Jump to navigation
Jump to search
scientific article published in October 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Versican V2 and the central inhibitory domain of Nogo-A inhibit neurite growth via p75NTR/NgR-independent pathways that converge at RhoA. |
scientific article published in October 2004 |
Statements
Versican V2 and the central inhibitory domain of Nogo-A inhibit neurite growth via p75NTR/NgR-independent pathways that converge at RhoA. (English)
1 reference
Rüdiger Schweigreiter
1 reference
Adrian R Walmsley
1 reference
Barbara Niederöst
1 reference
Dieter R Zimmermann
1 reference
Thomas Oertle
1 reference
Elisabeth Casademunt
1 reference
Stefan Frentzel
1 reference
Georg Dechant
1 reference
Anis Mir
1 reference
Christine E Bandtlow
1 reference
1 October 2004
1 reference
27
1 reference
2
1 reference
163-174
1 reference